Composition
- Active ingredients
- PEGINESATIDE ACETATE EQ 10MG BASE/ML (EQ 10MG BASE/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PEGINESATIDE ACETATE EQ 20MG BASE/2ML (EQ 10MG BASE/ML) · SolutionNDA202799-008 · Discontinued
- PEGINESATIDE ACETATE EQ 10MG BASE/ML (EQ 10MG BASE/ML) · SolutionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA202799.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Omontys
- Active substance
- peginesatide acetate
- Route
- Intravenous, Subcutaneous
- Dosage form
- Solution
- Applicant
- Takeda Pharms USA
- Status
- Discontinued
- FDA approval
- 27 Mar 2012
- Application
- NDA202799-007